Confirmed speakers

 

Tony Mire-Sluis AstraZeneca; Chair, IABS Human Therapeutics Committee

Jeff Baker FDA

Len Blackwell Biogen, Raleigh-Durham, North Carolina

Vinny Browning Amgen, Thousand Oaks, California

Barry Cherney Amgen, Washington, D.C.

Annie de Groot EpiVax, Providence, Rhode Island

Ping Hu Janssen R&D (Johnson and Johnson), Philadelphia, Pennsylvania

Ivar Kljavin Genentech, a member of the Roche Group, San Francisco, California

Yun Liu University of Delaware, Newark, Delaware

John Marino National Institute of Standards and Technology (NIST), Gaithersburg, Maryland

Ewa Marszal FDA

Ken Miller MedImmune, Baltimore, Maryland

Rajeev Ram Massachusetts Institute of Technology, Cambridge, Massachusetts

Oscar Salas-Solano Seattle Genetics, Bothell, Washington

Gopi Shankar Janssen Research & Development, LLC (JNJ),Philadelphia, Pennsylvania

John Stults Genentech, a Member of the Roche Group, San Francisco, California

Sriram Subramanian NIH, Bethesda, Maryland

Valerie Tsang Biogen, Raleigh-Durham, North Carolina

Florian Wolschin / Fabian Higel Novartis, Munich, Germany

Martin Zanni University of Wisconsin, Madison, Wisconsin